Skip to main content

Table 3 Course of disease in 526 patients with confirmed or probable P. vivax mono-infection

From: Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop

  Median IQ-Range
Days from end of journey to onset (nmiss = 80) 60 8–149
   with chemoprophylaxis 86 41–158
   without chemoprophylaxis 31 4–133
Days in hospital (nmiss = 400) 4 2–5
  N % of non missing
In-patients (nmiss = 7) 312 60.1
Complications (nmiss = 256) 30 11.1
   indicating treatment failure 23 8.5
   indicating severe disease 7 2.6
Fatalities (nmiss = 0) 0 0.0
  1. Nmiss= Number of cases disregarded due to missing data; IQ-Range = Inter-quartile range